Log in to your Inderes Free account to see all free content on this page.
Cessatech
17.95 DKK
+6.85 %
Less than 1K followers
CESSA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+6.85 %
+5.59 %
-20.75 %
+12.47 %
+41.34 %
+32.18 %
+1,004.62 %
-13.45 %
+66.44 %
Cessatech is a pivotal-stage paediatric biotech company developing first-in-class specialty hospital medicines for children, focused on high-impact unmet needs in acute and emergency care. The company focuses on specialty products designed for use in clinical settings and advances its programs through a partnership-based development model. Founded in 2020, Cessatech is headquartered in Denmark and led by a team with experience across drug development and commercialization.
Read moreMarket cap
333.45M DKK
Turnover
180.77K DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
28.5.
2026
Interim report Q1'26
28.8.
2026
Interim report Q2'26
26.11.
2026
Interim report Q3'26
All
Press releases
ShowingAll content types
Cessatech convenes its Annual General Meeting
Cessatech A/S Announces Financial Results for the Full Year 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio